0.0838
-0.0082
(-8.91%)
As of 8:08:31 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-58,531
-58,531
-55,672
-47,562
-44,125
Financing Cash Flow
59,201
59,201
5,215
36,190
95,638
End Cash Position
46,362
46,362
45,692
95,149
106,521
Issuance of Capital Stock
59,201
59,201
6,215
36,759
95,940
Free Cash Flow
-58,531
-58,531
-55,672
-47,562
-44,125
12/31/2021 - 3/14/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6DW.F D. Western Therapeutics Institute, Inc.
0.5750
+3.60%
0T20.F Traws Pharma, Inc.
0.0000
-100.00%
BTTAY Biotest Aktiengesellschaft
24.23
+6.27%
1HB0.F Scorpius Holdings, Inc.
0.0000
-100.00%
B1Q.F NRX Pharmaceuticals Inc. R
1.6300
+5.16%
APH0.F Ampio Pharmaceuticals, Inc.
3.6200
0.00%
2KZ0.F Kezar Life Sciences, Inc.
3.5000
-1.69%
6JU0.F BioCardia, Inc.
0.0000
-100.00%
2I9.F Karolinska Development AB (publ)
0.0641
+2.40%
2DE0.F Genprex, Inc.
0.0000
-100.00%